Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 760

1.

Identification of highly selective and potent orexin receptor 1 antagonists derived from a dual orexin receptor 1/2 antagonist based on the structural framework of pyrazoylethylbenzamide.

Futamura A, Nozawa D, Araki Y, Tamura Y, Tokura S, Kawamoto H, Tokumaru Y, Kakihara S, Aoki T, Ohtake N.

Bioorg Med Chem. 2017 Jul 29. pii: S0968-0896(17)31177-X. doi: 10.1016/j.bmc.2017.07.051. [Epub ahead of print]

PMID:
28807572
2.

Three-dimensional ultrastructural study of the anther of Silene latifolia infected with Microbotryum lychnidis-dioicae.

Kawamoto H, Hirata A, Kawano S.

PLoS One. 2017 Aug 9;12(8):e0182686. doi: 10.1371/journal.pone.0182686. eCollection 2017.

3.

Usefulness of a newly designed plastic stent for endoscopic re-intervention in patients with malignant hilar biliary obstruction.

Tomoda T, Kato H, Kawamoto H, Muro S, Akimoto Y, Uchida D, Matsumoto K, Horiguchi S, Tsutsumi K, Okada H.

Endoscopy. 2017 Jul 28. doi: 10.1055/s-0043-116215. [Epub ahead of print]

PMID:
28753695
4.

Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia.

Seki M, Kimura S, Isobe T, Yoshida K, Ueno H, Nakajima-Takagi Y, Wang C, Lin L, Kon A, Suzuki H, Shiozawa Y, Kataoka K, Fujii Y, Shiraishi Y, Chiba K, Tanaka H, Shimamura T, Masuda K, Kawamoto H, Ohki K, Kato M, Arakawa Y, Koh K, Hanada R, Moritake H, Akiyama M, Kobayashi R, Deguchi T, Hashii Y, Imamura T, Sato A, Kiyokawa N, Oka A, Hayashi Y, Takagi M, Manabe A, Ohara A, Horibe K, Sanada M, Iwama A, Mano H, Miyano S, Ogawa S, Takita J.

Nat Genet. 2017 Aug;49(8):1274-1281. doi: 10.1038/ng.3900. Epub 2017 Jul 3.

PMID:
28671687
5.

Reply: Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU (Gauging coronary Healing with bioresorbable Scaffolding plaTforms in EUrope) Registry.

Geraci S, Kawamoto H, Capodanno D, Caramanno G, Latib A.

JACC Cardiovasc Interv. 2017 Jun 26;10(12):1275-1276. doi: 10.1016/j.jcin.2017.05.013. No abstract available.

PMID:
28641853
6.

Response by Mitomo et al to Letter Regarding Article, "Bioresorbable Vascular Scaffolds for the Treatment of Chronic Total Occlusions: An International Multicenter Registry".

Mitomo S, Naganuma T, Fujino Y, Kawamoto H, Basavarajaiah S, Pitt M, Yin WH, Tresukosol D, Colombo A, Nakamura S.

Circ Cardiovasc Interv. 2017 Jun;10(6):e005299. doi: 10.1161/CIRCINTERVENTIONS.117.005299. No abstract available.

PMID:
28625966
7.

Conformational Change and Epimerization of Diketopiperazines Containing Proline Residue in Water.

Ishizu T, Tsutsumi H, Yokoyama E, Kawamoto H, Yokota R.

Chem Pharm Bull (Tokyo). 2017;65(6):598-602. doi: 10.1248/cpb.c17-00164.

8.

The Hybrid Assistive Limb® intervention for a postoperative patient with spinal dural arteriovenous fistula and chronic spinal cord injury: a case study.

Shimizu Y, Nakai K, Kadone H, Yamauchi S, Kubota S, Ueno T, Marushima A, Hiruta K, Endo A, Kawamoto H, Matsumura A, Sankai Y, Hada Y, Yamazaki M.

J Spinal Cord Med. 2017 May 29:1-8. doi: 10.1080/10790268.2017.1329916. [Epub ahead of print]

PMID:
28552031
9.

Long term follow-up of first generation versus new generation drug-eluting stents in three-vessel coronary artery disease.

Yoshizaki T, Naganuma T, Kobayashi T, Horikoshi T, Onishi H, Kawamoto H, Nakamura S, Nakamura S.

Cardiovasc Revasc Med. 2017 Apr 21. pii: S1553-8389(17)30121-5. doi: 10.1016/j.carrev.2017.04.006. [Epub ahead of print]

PMID:
28546033
10.

Phase I study of perifosine monotherapy in patients with recurrent or refractory neuroblastoma.

Matsumoto K, Shichino H, Kawamoto H, Kosaka Y, Chin M, Kato K, Mugishima H.

Pediatr Blood Cancer. 2017 May 18. doi: 10.1002/pbc.26623. [Epub ahead of print]

PMID:
28521076
11.

The E-Id Protein Axis Specifies Adaptive Lymphoid Cell Identity and Suppresses Thymic Innate Lymphoid Cell Development.

Miyazaki M, Miyazaki K, Chen K, Jin Y, Turner J, Moore AJ, Saito R, Yoshida K, Ogawa S, Rodewald HR, Lin YC, Kawamoto H, Murre C.

Immunity. 2017 May 16;46(5):818-834.e4. doi: 10.1016/j.immuni.2017.04.022.

PMID:
28514688
12.

Re-administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti-tuberculous therapy.

Kawamoto H, Takasaki J, Ishii S, Suzuki M, Morino E, Naka G, Iikura M, Izumi S, Takeda Y, Sugiyama H.

Respir Med Case Rep. 2017 Apr 15;21:147-150. doi: 10.1016/j.rmcr.2017.04.013. eCollection 2017.

13.

Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents.

Gili S, D'Ascenzo F, Di Summa R, Conrotto F, Cerrato E, Chieffo A, Boccuzzi G, Montefusco A, Ugo F, Omedé P, Kawamoto H, Tomassini F, Pavani M, Varbella F, Garbo R, D'Amico M, Biondi Zoccai G, Moretti C, Escaned J, Colombo A, Gaita F.

Am J Cardiol. 2017 Jul 1;120(1):33-39. doi: 10.1016/j.amjcard.2017.03.262. Epub 2017 Apr 12.

PMID:
28487035
14.

Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.

Watanabe Y, Takagi K, Naganuma T, Kawamoto H, Fujino Y, Ishiguro H, Tahara S, Kurita N, Hosawa K, Nakamura S, Nakamura S.

Int J Cardiol. 2017 Aug 1;240:108-113. doi: 10.1016/j.ijcard.2017.04.083. Epub 2017 Apr 26.

PMID:
28476515
15.

Walking ability following Hybrid Assistive Limb treatment for a patient with chronic myelopathy after surgery for cervical ossification of the posterior longitudinal ligament.

Kubota S, Abe T, Kadone H, Fujii K, Shimizu Y, Marushima A, Ueno T, Kawamoto H, Hada Y, Matsumura A, Sankai Y, Yamazaki M.

J Spinal Cord Med. 2017 Apr 20:1-9. doi: 10.1080/10790268.2017.1313932. [Epub ahead of print]

PMID:
28424026
16.

Design of high-quality compound library and open innovation.

Yamanobe S, Kawamoto H, Ohtake N.

Nihon Yakurigaku Zasshi. 2017;149(4):180-185. doi: 10.1254/fpj.149.180. No abstract available.

PMID:
28381662
17.

Active elbow flexion is possible in C4 quadriplegia using hybrid assistive limb (HAL®) technology: A case study.

Shimizu Y, Kadone H, Kubota S, Ikumi A, Abe T, Marushima A, Ueno T, Endo A, Kawamoto H, Saotome K, Matsushita A, Matsumura A, Sankai Y, Hada Y, Yamazaki M.

J Spinal Cord Med. 2017 Jul;40(4):456-462. doi: 10.1080/10790268.2017.1305036. Epub 2017 Mar 29.

PMID:
28355990
18.

Paradoxical response with increased tumor necrosis factor-α levels to anti-tuberculosis treatment in a patient with disseminated tuberculosis.

Watanabe S, Kaneko Y, Kawamoto H, Maehara T, Baba Y, Fujisaki I, Saito N, Ryu K, Seki A, Horikiri T, Kinoshita A, Takeda H, Saito K, Kuwano K.

Respir Med Case Rep. 2017 Feb 28;20:201-204. doi: 10.1016/j.rmcr.2017.02.011. eCollection 2017.

19.

Severe Aortic Stenosis With a Large Infra-aortic Annular Aneurysm of the Ventricular Septum Treated With CoreValve.

Naganuma T, Kawamoto H, Yabushita H, Nakao T, Nakamura S.

Can J Cardiol. 2017 May;33(5):688.e13-688.e15. doi: 10.1016/j.cjca.2017.01.014. Epub 2017 Jan 25. No abstract available.

PMID:
28318899
20.

Can we perform rotational atherectomy in patients with severe aortic stenosis? Substudy from the OCEAN TAVI Registry.

Naganuma T, Kawamoto H, Takagi K, Yabushita H, Mitomo S, Watanabe Y, Shirai S, Araki M, Tada N, Yamanaka F, Yamamoto M, Onishi H, Nakamura S, Higashimori A, Tabata M, Mizutani K, Ueno H, Hayashida K.

Cardiovasc Revasc Med. 2017 Jul - Aug;18(5):356-360. doi: 10.1016/j.carrev.2017.02.018. Epub 2017 Feb 28.

PMID:
28314673

Supplemental Content

Loading ...
Support Center